This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cipollone, F. Articles by Patrono, C. Search for Related Content PubMed PubMed Citation Articles by Cipollone, F. Articles by Patrono, C. Related Collections Clinical genetics Genetics of cardiovascular disease Other Vascular biology

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1516.)
© 2002 American Heart Association, Inc.

Editorials

Cyclooxygenase-2 Polymorphism

Putting a Brake on the Inflammatory Response to Vascular Injury?

Francesco Cipollone; Carlo Patrono

From the Atherosclerosis Prevention Center (F.C.), University of Chieti "G D’Annunzio" School of Medicine, Chieti, and Department of Pharmacology (C.P.), University of Rome "La Sapienza," Rome, Italy.

Correspondence to Carlo Patrono, MD, Università di Roma "La Sapienza," II Facoltà di Medicina e Chirurgia, Via di Grottarossa, 1035, 00189 Rome, Italy. E-mail cpatrono@unich.it

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Prostaglandin endoperoxide H synthase (PGHS) catalyzes the conversion of arachidonic acid to PGH₂, the first committed step in the biosynthesis of a range of lipid mediators, termed prostaglandins (PGs) and thromboxanes.¹ PGHS has both cyclooxygenase (COX) and hydroperoxidase activities.² Aspirin and a variety of nonsteroidal antiinflammatory drugs (NSAIDs) inhibit the COX activity of PGHS³ (Figure 1).

View larger version (38K): [in this window] [in a new window]   Figure 1. The cyclooxygenase pathways of arachidonic acid metabolism. The figure depicts the constitutive pathway on the left side and the inducible pathway of arachidonic acid metabolism on the right side, generating the same lipid mediator, ie, prostaglandin E2, through a cascade of coordinate enzymatic reactions. It also illustrates the site of action of low-dose aspirin and coxibs in inhibiting selectively COX-1 and COX-2, respectively. Traditional nonsteroidal antiinflammatory drugs inhibit nonselectively both isozymes. AA indicates arachidonic acid; EP1,2,3,4, specific PGE2 receptors; LPS, lipopolysaccharide; PGE2, prostaglandin E2; PGH2, prostaglandin H2; PLA2, phospoholipase A2; PGES, PGE-synthase (c and m denote the constitutive and inducible isoforms of the enzyme, respectively).

See p 1631

Before 1991, only the isoform called PGHS-1, COX-1, or the constitutive enzyme had been described. At that time, Xie et al⁴ and Kujubu and Herschman⁵ discovered mRNAs whose expression was induced in chicken and mouse fibroblasts in response to src and tumor-promoting phorbol esters, respectively, and that encoded proteins having 60% amino acid sequence identity with COX-1. Subsequent work has shown that the new protein, called PGHS-2, COX-2, or the inducible isoform, is . . . [Full Text of this Article]

This article has been cited by other articles:

				A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF]

				O. Beloqui, J. A. Paramo, J. Orbe, A. Benito, I. Colina, A. Monasterio, and J. Diez Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors? Eur. Heart J., January 2, 2005; 26(2): 153 - 158. [Abstract] [Full Text] [PDF]

				D. L. Simmons, R. M. Botting, and T. Hla Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition Pharmacol. Rev., September 1, 2004; 56(3): 387 - 437. [Abstract] [Full Text] [PDF]

				F. Cipollone, E. Toniato, S. Martinotti, M. Fazia, A. Iezzi, C. Cuccurullo, B. Pini, S. Ursi, G. Vitullo, M. Averna, et al. A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke JAMA, May 12, 2004; 291(18): 2221 - 2228. [Abstract] [Full Text] [PDF]

				F. Cipollone, B. Rocca, and C. Patrono Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 246 - 255. [Abstract] [Full Text]